Skip to content
OpenSampling

2021 · BMC pregnancy and childbirth · open access

Safe threshold of capillary blood glucose for predicting early future neonatal hypoglycaemia in babies born to mothers with gestational diabetes mellitus, an observational, retrospective cohort study

Park et al.

The finding, in our words

A capillary blood glucose threshold of 2.6 mmol/L measured before the second feed predicted neonatal hypoglycaemia within 24 hours with an area under the ROC curve of 0.96. This could allow 60 per cent of babies born to mothers with gestational diabetes to avoid extended inpatient monitoring, enabling earlier discharge and home-based care.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2026

    This study validated a method requiring only 10 microlitres of serum and found high agreement between fingerstick capillary samples and venous serum for monitoring twelve antibiotics. The results suggest capillary serum sampling is a feasible, minimally invasive alternative that avoids the haematocrit effect associated with whole blood microsampling.

    Feasibility verification of fingerstick capillary microsampling replacing venipuncture for therapeutic drug monitoring of 12 antibiotics using a rapid LC-MS/MS assayChen et al., Talanta (paywalled) · source ↗

    • blood
    • liquid
    • capillary
    • validation
    • venous-agreement
    • pediatric
    • tdm
    • antimicrobials
  2. 2024

    In 91 children and adults, capillary C-peptide taken with the TAP device matched venous sampling with 100% sensitivity and specificity for a clinically relevant level, 200 pmol/L or above, with r = 0.996. 63% preferred it to a needle against 7% who preferred the needle, and same-day bruising was 5.5% versus 34.8% after a venous draw.

    Transdermal blood sampling for C-peptide is a minimally invasive, reliable alternative to venous sampling in children and adults with type 1 diabetesBesser et al., Diabetes Care · source ↗

    • blood
    • liquid
    • yourbio
    • capillary
    • pediatric
    • venous-agreement
    • acceptability
    • validation
  3. 2024

    In at-home and trial settings, a wet capillary device reliably collected a median ~450 µL with a 4.4% failure rate; 88% of adults preferred self-collection over venipuncture, with lower pain.

    Feasibility, acceptability and safety of a device for self-collecting capillary blood in clinical trialsDasari et al., PLOS ONE · source ↗

    • dct
    • acceptability
    • blood
    • self-collection
    • capillary
    • pediatric
    • liquid
    • validation
  4. 2024

    Adolescents collecting blood microsamples at home achieved varying success rates across six devices, with Minicollect tubes performing poorest. The confirmation that visual inspection alone was insufficient, by analytical variability, underscores the need for robust quality assessment before deploying any device in decentralised trials.

    Self-Sampling by Adolescents at Home: Assessment of the Feasibility to Successfully Collect Blood Microsamples by Inexperienced IndividualsBoffel et al., The AAPS journal (paywalled) · source ↗

    • blood
    • liquid
    • dried
    • capillary
    • vams
    • dbs
    • neoteryx-mitra
    • self-collection
    • acceptability
    • pediatric
    • dct
  5. 2022

    The paper records that the TAP II devices used for the infant draws were provided by YourBio Health, and that capillary serum was collected from babies as young as two months: the smallest patients sampled, without a heel prick or a venepuncture.

    Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infectionShook, Edlow et al., JAMA · source ↗

    • blood
    • liquid
    • yourbio
    • capillary
    • pediatric
    • serology